Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 12/20 | 0.97 |
| ▸ | SPHK1 | Q9NYA1 | 12/20 | 0.97 |
| ▸ | MAPT | P10636 | 4/20 | 0.97 |
| ▸ | MEN1 | O00255 | 3/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.97 |
| ▸ | CETP | P11597 | 3/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | GMNN | O75496 | 2/20 | 0.97 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | GLA | P06280 | 2/20 | 0.97 |
| ▸ | POLB | P06746 | 2/20 | 0.97 |
| ▸ | THRB | P10828 | 2/20 | 0.97 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.97 |
| ▸ | CCR6 | P51684 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | UBE2N | P61088 | 2/20 | 0.97 |
| ▸ | TP53 | P04637 | 2/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sphingosine SCHEMBL195874 | 1.00 | SPHK2 (0.97) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL27975296 | 1.00 | SPHK2 (0.97) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL2306197 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL21428474 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL6348073 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL22986939 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL22911044 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| Sphingosine SCHEMBL21114357 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL21428477 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A | |
| SCHEMBL22986843 | 0.98 | SPHK2 (1.00) | SPHK2SPHK1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024013306-A1 | COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF | GAT THERAPEUTICS, S.L. (ES) | 2024-01-18 | — | — | WO | disclosed |
| EP-4306101-A1 | COMPOSITIONS COMPRISING AMAROUCIAXANTHIN A ESTERS AND USES THEREOF | Gat Therapeutics S.L. (ES) | 2024-01-17 | — | — | EP | disclosed |
| US-20160152735-A1 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | APOLLO ENDOSURGERY, INC. | 2016-06-02 | — | — | US | disclosed |
| US-20160146844-A1 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | APOLLO ENDOSURGERY, INC. | 2016-05-26 | — | — | US | disclosed |
| EP-2164992-B1 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | LPATH INC (US) | 2016-05-04 | — | — | EP | disclosed |
| US-9274129-B2 | Methods and reagents for detecting bioactive lipids | LPATH, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-9217749-B2 | Immune-derived moieties reactive against lysophosphatidic acid | LPATH, INC. (US) | 2015-12-22 | — | — | US | disclosed |
| US-9163091-B2 | Compositions and methods for binding lysophosphatidic acid | LPATH, INC. (US) | 2015-10-20 | — | — | US | disclosed |
| CN-104650225-A | COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE | LPATH INC | 2015-05-27 | — | — | CN | disclosed |
| CN-101679506-B | Compositions and methods for binding sphingosine-1-phosphate | LPATH INC | 2015-02-25 | — | — | CN | disclosed |
| US-20020151060-A1 | PEI: DNA vector formulations for in vitro and in vivo gene delivery | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-10-17 | — | — | US | disclosed |
| US-20020143062-A1 | Method to incorporate N-(4-hydroxyphenyl) retinamide in liposomes | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-10-03 | — | — | US | disclosed |
| WO-2001025255-A9 | NOVEL ZINC FINGER PROTEIN | BAYLOR COLLEGE MEDICINE (US) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002069886-A2 | MODIFIED PROTEINS, DESIGNER TOXINS, AND METHODS OF MAKING THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002060412-A2 | STABILISED POLYMERIC AEROSOLS FOR PULMONARY GENE DELIVERY | BOARD OF REGENTS (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002041871-A2 | COMPOSITION COMPRISING AN IMEXON OR DERIVATIVES THEREOF AND LIPIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002036624-A2 | METHODS, COMPOSITIONS AND THERAPEUTIC APPLICATIONS RELATING TO FORTILIN (= TRANSLATIONALLY CONTROLLED TUMOR PROTEIN, TCTP) AND MODULATORS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-05-10 | — | — | WO | disclosed |
| WO-2002032413-A2 | A METHOD TO INCORPORATE N-(4-HYDROXYPHENYL) RETINAMIDE IN LIPOSOMES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002024232-A2 | PEI: DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-03-28 | — | — | WO | disclosed |
| WO-2001025255-A2 | NOVEL ZINC FINGER PROTEIN | BAYLOR COLLEGE OF MEDICINE (US) | 2001-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152735-A1 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID | LPAR2, LPAR3, LPAR5 | SPHK2 150/4885SPHK1 237/4885MAPT 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.